肝细胞-话题@MedSci

#肝细胞#

513篇内容 | 2122人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1863595, encodeId=4a53186359517, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Nat Cancer：新辅助治疗药物卡博替尼和纳武单抗治疗局部晚期肝细胞癌, objectType=article, longId=215171, objectId=df392151e1d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df392151e1d8, replyNumber=0, likeNumber=65, createdTime=2022-06-16, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df392151e1d8, moduleTitle=Nat Cancer：新辅助治疗药物卡博替尼和纳武单抗治疗局部晚期肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df392151e1d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863539, encodeId=b28c18635397b, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=GUT：HBV整合促进肝细胞癌局部及远距离致癌驱动因子的改变, objectType=article, longId=207042, objectId=aaa020e042e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaa020e042e3, replyNumber=0, likeNumber=80, createdTime=2021-06-16, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaa020e042e3, moduleTitle=GUT：HBV整合促进肝细胞癌局部及远距离致癌驱动因子的改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaa020e042e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863617, encodeId=3418186361e5f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响, objectType=article, longId=219336, objectId=97b7219336b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97b7219336b4, replyNumber=0, likeNumber=65, createdTime=2022-04-02, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97b7219336b4, moduleTitle=Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97b7219336b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863566, encodeId=39a1186356665, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Dig Dis Sci：中性粒细胞-淋巴细胞比率较高与肝细胞癌患者死亡率增加相关, objectType=article, longId=211890, objectId=c50f211890e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c50f211890e4, replyNumber=0, likeNumber=86, createdTime=2022-05-02, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c50f211890e4, moduleTitle=Dig Dis Sci：中性粒细胞-淋巴细胞比率较高与肝细胞癌患者死亡率增加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c50f211890e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863540, encodeId=efac1863540b5, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Nature BME:一种未检测到RNA和DNA脱靶突变的肝细胞内胞苷碱基编辑方法, objectType=article, longId=207212, objectId=f0d420e212b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0d420e212b2, replyNumber=0, likeNumber=63, createdTime=2021-11-27, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0d420e212b2, moduleTitle=Nature BME:一种未检测到RNA和DNA脱靶突变的肝细胞内胞苷碱基编辑方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0d420e212b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863611, encodeId=cf47186361107, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Br J Cancer：晚期肝细胞癌患者诊断性活检的可行性分析, objectType=article, longId=218510, objectId=91142185104b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91142185104b, replyNumber=0, likeNumber=50, createdTime=2022-02-07, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91142185104b, moduleTitle=Br J Cancer：晚期肝细胞癌患者诊断性活检的可行性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91142185104b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863537, encodeId=a233186353e47, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Nat Commun：肝细胞多倍体化诱导肝细胞癌癌前病变的发生, objectType=article, longId=206848, objectId=152c206848c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=152c206848c1, replyNumber=0, likeNumber=100, createdTime=2021-04-13, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=152c206848c1, moduleTitle=Nat Commun：肝细胞多倍体化诱导肝细胞癌癌前病变的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=152c206848c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863550, encodeId=cd4b186355067, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Dig Dis Sci: 甲胎蛋白水平是肝细胞癌患者根治性切除的重要指标, objectType=article, longId=209598, objectId=236c2095982f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=236c2095982f, replyNumber=0, likeNumber=60, createdTime=2022-01-11, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=236c2095982f, moduleTitle=Dig Dis Sci: 甲胎蛋白水平是肝细胞癌患者根治性切除的重要指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=236c2095982f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863588, encodeId=23121863588eb, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系, objectType=article, longId=214297, objectId=744721429ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744721429ee4, replyNumber=0, likeNumber=108, createdTime=2022-06-25, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744721429ee4, moduleTitle=AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=744721429ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863582, encodeId=44cb186358290, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=JAMA Netw Open：肝细胞癌超声筛查：间隔少于 6 个月更佳, objectType=article, longId=213329, objectId=17e521332904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17e521332904, replyNumber=0, likeNumber=81, createdTime=2022-05-07, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17e521332904, moduleTitle=JAMA Netw Open：肝细胞癌超声筛查：间隔少于 6 个月更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17e521332904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863548, encodeId=4966186354852, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=“特瑞普利单抗+贝伐珠单抗”一线治疗晚期肝细胞癌临床研究新近进展发布, objectType=article, longId=208886, objectId=8dd6208886d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dd6208886d9, replyNumber=0, likeNumber=0, createdTime=2021-07-05, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dd6208886d9, moduleTitle=“特瑞普利单抗+贝伐珠单抗”一线治疗晚期肝细胞癌临床研究新近进展发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8dd6208886d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863587, encodeId=e662186358e3d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Clin Cancer Res：预测仑伐替尼（Lenvatinib）在不可切除肝细胞癌中生存获益的药效学生物标志物:来自III期REFLECT研究, objectType=article, longId=214268, objectId=9fbc2142681c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fbc2142681c, replyNumber=0, likeNumber=73, createdTime=2021-11-20, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fbc2142681c, moduleTitle=Clin Cancer Res：预测仑伐替尼（Lenvatinib）在不可切除肝细胞癌中生存获益的药效学生物标志物:来自III期REFLECT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fbc2142681c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863541, encodeId=869b186354122, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Eur Radiol:肝特异性MR对比剂除了能鉴别肝细胞肝癌还能做什么？, objectType=article, longId=207534, objectId=64ad20e53415, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64ad20e53415, replyNumber=0, likeNumber=54, createdTime=2021-04-18, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64ad20e53415, moduleTitle=Eur Radiol:肝特异性MR对比剂除了能鉴别肝细胞肝癌还能做什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64ad20e53415)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863586, encodeId=476218635866e, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Liver Cancer：雷莫芦单抗（Ramucirumab）治疗甲胎蛋白升高的中期肝细胞癌（HCC）患者的疗效:来自两项3期研究(REACH和REACH-2)的汇总结果, objectType=article, longId=214189, objectId=ceaa214189f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ceaa214189f7, replyNumber=0, likeNumber=78, createdTime=2021-09-27, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ceaa214189f7, moduleTitle=Liver Cancer：雷莫芦单抗（Ramucirumab）治疗甲胎蛋白升高的中期肝细胞癌（HCC）患者的疗效:来自两项3期研究(REACH和REACH-2)的汇总结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ceaa214189f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863551, encodeId=8c74186355149, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=World J Gastroenterology：化学栓塞术对肝细胞癌患者短期和长期预后的影响, objectType=article, longId=209642, objectId=0bbc2096428f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bbc2096428f, replyNumber=0, likeNumber=63, createdTime=2021-09-06, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bbc2096428f, moduleTitle=World J Gastroenterology：化学栓塞术对肝细胞癌患者短期和长期预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bbc2096428f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863555, encodeId=229418635558a, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Clin Gastroenterol H：非酒精性脂肪肝患者肝细胞癌发病率分析, objectType=article, longId=210958, objectId=23f22109581e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23f22109581e, replyNumber=0, likeNumber=61, createdTime=2021-10-23, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23f22109581e, moduleTitle=Clin Gastroenterol H：非酒精性脂肪肝患者肝细胞癌发病率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23f22109581e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863589, encodeId=c57818635893f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Liver Cancer：不可切除肝细胞癌患者基线肝功能和预后的关系：来自3期临床研究REFLECT患者的分析结果, objectType=article, longId=214329, objectId=ec54214329a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec54214329a3, replyNumber=0, likeNumber=54, createdTime=2021-12-02, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec54214329a3, moduleTitle=Liver Cancer：不可切除肝细胞癌患者基线肝功能和预后的关系：来自3期临床研究REFLECT患者的分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec54214329a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863545, encodeId=eb2b18635459a, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Eur Radiol:脾脏体积还能与肝细胞癌切除术后肝功能衰竭以及术后总生存率有关系？, objectType=article, longId=207979, objectId=7a1420e979e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a1420e979e8, replyNumber=0, likeNumber=51, createdTime=2021-11-12, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a1420e979e8, moduleTitle=Eur Radiol:脾脏体积还能与肝细胞癌切除术后肝功能衰竭以及术后总生存率有关系？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a1420e979e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863567, encodeId=8203186356e79, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=ASCO 2021: 摘要概览与展望 6 | 肝细胞癌重磅研究一览, objectType=article, longId=211894, objectId=b2b42118942f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2b42118942f, replyNumber=0, likeNumber=94, createdTime=2021-09-18, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2b42118942f, moduleTitle=ASCO 2021: 摘要概览与展望 6 | 肝细胞癌重磅研究一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2b42118942f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863563, encodeId=409c186356303, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Hepatol Int：安罗替尼（Anlotinib）治疗晚期肝细胞癌（HCC）的疗效和安全性：来自ALTER‑0802研究结果, objectType=article, longId=211682, objectId=d50921168225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d50921168225, replyNumber=0, likeNumber=74, createdTime=2022-05-03, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d50921168225, moduleTitle=Hepatol Int：安罗替尼（Anlotinib）治疗晚期肝细胞癌（HCC）的疗效和安全性：来自ALTER‑0802研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d50921168225)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝细胞

2020-05-29

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Nat Cancer：新辅助治疗药物卡博替尼和纳武单抗治疗局部晚期肝细胞癌

2022-06-16

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

GUT：HBV整合促进肝细胞癌局部及远距离致癌驱动因子的改变

2021-06-16

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响

2022-04-02

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Dig Dis Sci：中性粒细胞-淋巴细胞比率较高与肝细胞癌患者死亡率增加相关

2022-05-02

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Nature BME:一种未检测到RNA和DNA脱靶突变的肝细胞内胞苷碱基编辑方法

2021-11-27

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Br J Cancer：晚期肝细胞癌患者诊断性活检的可行性分析

2022-02-07

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Nat Commun：肝细胞多倍体化诱导肝细胞癌癌前病变的发生

2021-04-13

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Dig Dis Sci: 甲胎蛋白水平是肝细胞癌患者根治性切除的重要指标

2022-01-11

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系

2022-06-25

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

JAMA Netw Open：肝细胞癌超声筛查：间隔少于 6 个月更佳

2022-05-07

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

“特瑞普利单抗+贝伐珠单抗”一线治疗晚期肝细胞癌临床研究新近进展发布

2021-07-05

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Clin Cancer Res：预测仑伐替尼（Lenvatinib）在不可切除肝细胞癌中生存获益的药效学生物标志物:来自III期REFLECT研究

2021-11-20

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Eur Radiol:肝特异性MR对比剂除了能鉴别肝细胞肝癌还能做什么？

2021-04-18

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Liver Cancer：雷莫芦单抗（Ramucirumab）治疗甲胎蛋白升高的中期肝细胞癌（HCC）患者的疗效:来自两项3期研究(REACH和REACH-2)的汇总结果

2021-09-27

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

World J Gastroenterology：化学栓塞术对肝细胞癌患者短期和长期预后的影响

2021-09-06

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Clin Gastroenterol H：非酒精性脂肪肝患者肝细胞癌发病率分析

2021-10-23

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Liver Cancer：不可切除肝细胞癌患者基线肝功能和预后的关系：来自3期临床研究REFLECT患者的分析结果

2021-12-02

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Eur Radiol:脾脏体积还能与肝细胞癌切除术后肝功能衰竭以及术后总生存率有关系？

2021-11-12

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

ASCO 2021: 摘要概览与展望 6 | 肝细胞癌重磅研究一览

2021-09-18

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Hepatol Int：安罗替尼（Anlotinib）治疗晚期肝细胞癌（HCC）的疗效和安全性：来自ALTER‑0802研究结果

2022-05-03

科室
- - 订阅+
  - 更多科室
工具
服务